Lasa Supergenerics Limited has informed the Exchange regarding Cessation of MR. PRATHMESH CHALKE as Executive Director of the company w.e.f. December 31, 2025.
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics Limited has informed the stock exchange that Mr. Prathmesh Chalke will cease to hold the position of Executive Director of the company with effect from December 31, 2025. An Executive Director is part of the company's Key Managerial Personnel (KMP), actively involved in day-to-day management. The reasons for cessation have not been disclosed in this filing. Shareholders may await the company's next quarterly filing or a separate board update for further details on the circumstances. The cessation takes effect at the close of the current financial year.
Loss of an Executive Director can create short-term uncertainty around leadership continuity and operational decision-making, which may weigh on investor sentiment. Retail investors should watch for the company's reason for the departure and any replacement announcement.